Ranbaxy laboratories News: Ranbaxy laboratories Latest News, Ranbaxy laboratories Today news, Ranbaxy laboratories Breaking News

THE TRUTH PILL The Myth of Drug Regulation in India, THE TRUTH PILL The Myth of Drug Regulation in India book review, THE TRUTH PILL The Myth of Drug Regulation in India author,

A reminder how policy leaders, pharma industry, drug regulators & activists need a trust pill to cure public health

December 18, 2022 01:15 IST

ICGEB and Sun Pharma sign agreement to develop botanical drug to treat dengue

ICGEB will provide the technical know-how and pre-clinical expertise and Sun Pharma to develop this drug with appropriate pre-clinical &…

May 5, 2016 17:53 IST

Sun completes sale of two Ranbaxy divisions to Strides Shasun

The agreement involved transfer of these two marketing divisions, along with employees to Strides, for Rs 165 crore Sun Pharmaceutical…

February 3, 2016 10:02 IST

Ranbaxy, Ranbaxy nexium, Ranbaxy medicines, Ranbaxy USFDA , USFDA, Nexium

Cipher, Ranbaxy settle patent litigation with Actavis

Cipher Pharma Inc, along with partners Ranbaxy – a Sun Pharma firm – and Galephar Pharmaceutical Research, has entered into…

October 5, 2015 20:59 IST

Sun Pharma to sell Ranbaxy’s 2 CNS divisions to Strides Arcolab for Rs 165 crore

Sun Pharma is selling erstwhile Ranbaxy’s two divisions ‘Solus’ and ‘Solus Care’ divisions in central nervous system (CNS) segment in…

September 19, 2015 15:14 IST

Sun Pharma looking to divest Ireland plant

The company is trying to control costs that have spiralled since it bought Ranbaxy Laboratories Sun Pharmaceutical Industries is looking…

Updated: September 10, 2015 09:01 IST

Sun Pharma posts net profit of Rs 479 crores Q1FY16

Net sales has been registered at Rs 6,522 crores Sun Pharmaceutical Industries has posted its financials for first quarter ending…

August 12, 2015 09:28 IST

Integration with Ranbaxy may hit Sun Pharma profit

The country’s largest drugmaker Sun Pharmaceutical said it expects consolidated profit for FY16 to be adversely impacted…

July 21, 2015 00:26 IST

Sun Pharma asks 18 top Ranbaxy executives to leave

Those who have been asked to resign are Indrajit Banerjee, President and CFO; Yugal Sikri, country head (India) Ranbaxy; Maninder…

Updated: June 18, 2015 16:59 IST

For Daiichi, side effects of Ranbaxy refuse to wane

Clause may hold it liable for penalty payout of $325 million

May 15, 2015 01:03 IST

After the fall, Sun Pharma shares rebound on value buying, rise 3 pct

Stocks of Sun Pharmaceutical made a comeback at the bourses today, rising nearly 3 per cent, a day after Japanese…

April 22, 2015 14:59 IST

Daiichi’s $3.6 bn exit from Sun Pharmaceutical hits rupee, stocks

Concerns about foreign outflows weigh after Japan’s Daiichi Sankyo’s $3.6 billon share sale in Sun Pharmaceutical Industries.

April 21, 2015 14:46 IST

Japan’s Daiichi Sankyo sells Sun Pharma stake

Daiichi Sankyo said it would disclose the financial details related to the Sun Pharma stake sale when it announces results…

April 21, 2015 12:10 IST

RSF honours outstanding scientists

21st Annual Symposium on ‘Neurodegeneration’ was also held

April 5, 2015 09:55 IST

Sun Pharma closes merger deal with Ranbaxy

The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations

April 5, 2015 08:15 IST

Sun Pharma gets RBI nod for transfer of Ranbaxy overseas investments

Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares…

March 24, 2015 17:28 IST

Ranbaxy Science Foundation honours outstanding scientists and young science scholars

Ranbaxy Science Foundation (RSF), a non-profit organisation set-up by Ranbaxy Laboratories (Ranbaxy) announced Ranbaxy Research Awards for excellence in original…

March 10, 2015 12:17 IST

ranbaxy delisting, ranbaxy delisting news, Ranbaxy, ranbaxy india, ranbaxy news, Sun Pharma, Sun Pharmaceutical, sun pharma, sun pharma ranbaxy, sun pharma ranbaxy deal, sun pharma ranbaxy merger news, Indian Stock Exchanges, BSE Sensex, BSE

Ranbaxy loses approvals, exclusivity of 2 drugs in US

Ranbaxy Laboratories’ tentative approvals for its generic versions of digestive disorder drug Nexium and antiviral Valcyte…

March 3, 2015 17:17 IST

Ranbaxy Laboratories

Related News

Photo Gallery

Onam 2025: Colourful pookalams to delicious Sadya feasts; how India is celebrating Thiruvonam

Trending Topics